REFERENCE
  1. Lower R: Treatment of Heart[in Latin]. London: Allestry;1669.
  2. Wang FF, Hsu J, Jia FW, et al: Left ventricular strain is associated with acute postoperative refractory hypotension in patients with constrictive pericarditis and preserved ejection fraction. J Thorac Dis 2018:10(7):4147-4155.
  3. Pessinaba S, Sonhaye L, Agbétiafa M, et al: The chronic constrictive pericarditis, a real calcified gangue realizing a mid-ventricular bottleneck: A case report. Ann Cardiol Angeiol(Paris) 2019:68(2):125-128.
  4. Albarrán AA, González JAB, García JMM: ”Malignant” Chronic Constrictive Pericarditis. Eurasian J Med 2018:50(2):140.
  5. Bhembe NL, Green E: Molecular epidemiological study of multidrug-resistant tuberculosis isolated from sputum samples in Eastern Cape, South Africa. Infect Genet Evol 2020:80:104182.
  6. Fowler NO: Tuberculous pericarditis. JAMA 1991:266(1):99-103.
  7. Ntsekhe M, Mayosi BM: Tuberculous pericarditis with and without HIV. Heart Fail Rev 2013:18(3):367-373.
  8. Smith I: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003:16(3):463-496.
  9. Sudre P, ten Dam G, Kochi A: Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992:70(2):149-159.
  10. World Health Organization: Global tuberculosis report 2019 WHO/CDS/TB/2019.15. Geneva; 2019.
  11. World Health Organization: The end TB strategy. Geneva, Switzerland: 2015.
  12. Walker TM, Merker M, Knoblauch AM, et al: A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis 2018:18(4):431-440.
  13. Glaziou P, Floyd K, Raviglione MC: Global Epidemiology of Tuberculosis. Semin Respir Crit Care Med 2018:39(3):271-285.
  14. Loveday M, Hughes J, Sunkari B, et al: Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa. Clin Infect Dis 2020:ciaa189.
  15. UNAIDS: Global AIDS update 2018[M]. Geneva: UNAIDS, 2018:12-18.
  16. Mastroianni A, Coronado O, Chiodo F: Tuberculous pericarditis and AIDS: case reports and review. Eur J Epidemiol 1997:13(7):755-759.
  17. Mtabho CM, Semvua HH, van den Boogaard J, et al: Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients. J Antimicrob Chemother 2019:74(12):3537-3545.
  18. Bates MN, Khalakdina A, Pai M, et al: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007:167(4):335-342.
  19. Wallace D, Wallace R: Problems with the WHO TB model. Math Biosci 2019:313:71-80.
  20. López MG, Dogba JB, Torres-Puente M, et al: Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events. Microb Genom 2020:6(1):e000325.
  21. SPODICK DH: Tuberculous pericarditis. AMA Arch Intern Med 1956:98(6):737-749.
  22. Mayosi BM, Burgess LJ, Doubell AF: Tuberculous pericarditis. Circulation 2005:112(23):3608-3616.
  23. Syed FF, Mayosi BM: A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 2007:50(3):218-236.
  24. Reuter H, Burgess LJ, Schneider J, et al: The role of histopathology in establishing the Diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology 2006:48(3):295-302.
  25. Hakim JG, Ternouth I, Mushangi E, et al: Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000:84(2):183-188.
  26. Ronacher K, Joosten SA, van Crevel R, et al: Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol Rev 2015:264(1):121-137.
  27. Gomez DI, Twahirwa M, Schlesinger LS, et al: Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis 2013:93(2):192-197.
  28. Tack CJ, Stienstra R, Joosten LA, et al: Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev 2012:249(1):239-252.
  29. Neyrolles O, Hernández-Pando R, Pietri-Rouxel F, et al: Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One 2006:1(1):e43.
  30. Mathad JS, Gupta A: Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps. Clinical Infectious Diseases 2012:55(11):1532-1549.
  31. Klein AL, Abbara S, Agler DA, et al: American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013:26(9):965-1012.
  32. Adler Y, Charron P, Imazio M, et al: 2015 ESC Guidelines for the Diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015:36(42):2921-2964.
  33. Hoit BD: Pathophysiology of the Pericardium. Prog Cardiovasc Dis 2017:59(4):341-348.
  34. Tuck BC, Townsley MM: Clinical Update in Pericardial Diseases. J Cardiothorac Vasc Anesth 2019:33(1):184–199.
  35. D’Elia E, Ferrazzi P, Imazio M, et al: Constrictive pericarditis: a common pathophysiology for different macroscopic anatomies. J Cardiovasc Med (Hagerstown) 2019:20(10):725-726.
  36. Ntsekhe M, Matthews K, Syed FF, et al: Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion. PLoS One 2013:8(10):e77532.
  37. Reuter H, Burgess L, van Vuuren W, et al: Diagnosing tuberculous pericarditis. QJM 2006:99(12):827-839.
  38. Tuon FF, Litvoc MN, Lopes MI: Adenosine deaminase and tuberculous pericarditis–a systematic review with meta-analysis. Acta Trop 2006:99(1):67-74.
  39. Miranda WR, Oh JK: Constrictive Pericarditis: A Practical Clinical Approach. Prog Cardiovasc Dis 2017:59(4):369-379.
  40. Welch TD: Constrictive pericarditis: Diagnosis, management and clinical outcomes. Heart 2018:104(9):725-731.
  41. Maron BJ, Friedman RA, Kligfield P, et al: Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation 2014:130(15):1303-1334.
  42. Morris JJ Jr, Estes EH Jr, Whalen RE, et al: P-wave analysis in valvular heart disease. Circulation 1964:29:242-252.
  43. Ren Y, Qiu J, Li Z, et al: P-wave terminal force in lead V1 is a predictive indicator for the Diagnosis of tuberculous constrictive pericarditis. Heart Lung 2019:48(2):155-158.
  44. Welch TD, Ling LH, Espinosa RE, et al: Echocardiographic Diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circ Cardiovasc Imaging 2014:7(3):526-534.
  45. Reuss CS, Wilansky SM, Lester SJ, et al: Using mitral’ annulus reversus’ to diagnose constrictive pericarditis. Eur J Echocardiogr 2009:10(3):372-375.
  46. Jottrand E, Serste T, Mulkay JP, et al: Longitudinal strain by speckle tracking echocardiography in constrictive pericarditis. Eur Heart Cardiovasc Imaging 2018:19(6):638.
  47. Madeira M, Teixeira R, Costa M, et al: Two-dimensional speckle tracking cardiac mechanics and constrictive pericarditis: systematic review. Echocardiography 2016:33(10):1589-1599.
  48. Anavekar NS, Wong BF, Foley TA, et al: Index of biventricular interdependence calculated using cardiac MRI: a proof of concept study in patients with and without constrictive pericarditis. Int J Cardiovasc Imaging 2013:29(2):363-369.
  49. Carrascosa PM, Deviggiano A, Rodríguez-Granillo GA: Pericardial Disease. Clinical Atlas of Cardiac and Aortic CT and MRI[M]. Switzerland: Springer,2019:309-326.
  50. Zurick AO, Bolen MA, Kwon DH, et al: Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging 2011:4(11):1180-1191.
  51. Dong A, Dong H, Wang Y, et al: (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin Nucl Med 2013:38(4):e160-e165.
  52. Kim MS, Kim EK, Choi JY, et al: Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease. Curr Cardiol Rep 2019:21(9):107.
  53. Mutyaba AK, Ntsekhe M: Tuberculosis and the Heart. Cardiol Clin 2017:35(1):135-144.
  54. Chang SA: Tuberculous and Infectious Pericarditis. Cardiol Clin 2017:35(4):615-622.
  55. Shenje J, Ifeoma Adimora-Nweke F, Ross IL, et al: Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis. EBioMedicine 2015:2(11):1640–1649.
  56. Metaxas EI, Kotsifas K, Tatsis G, et al: Tuberculous pericarditis: three cases and brief review. Monaldi Arch Chest Dis 2010:73(1):44-50.
  57. Ak K, Demirbas E, Atas H, et al: Results of pericardiectomy for constrictive pericarditis: Single-center experience. Herz 2017:42(1):75-83.
  58. Falzon D, Schünemann HJ, Zignol M, et al: WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence. Eur Respir J 2020:55(3):1902325.
  59. World Health Organization: Guidelines for treatment of drug susceptible tuberculosis and patient care, 2017 update. Geneva, Switzerland: WHO, 2017.
  60. Klopfenstein HS: The pathophysiology of pericardial disease–contributions derived from echocardiography/Doppler studies in animal models. Echocardiography 1990:7(1):5-9.
  61. Tsui CY, Burch GE: Coxsackie virus B4 pericarditis in mice. Br J Exp Pathol 1971:52(1):47-50.
  62. Matsumori A, Kawai C: Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle. J Pathol 1980:131(2):97-106.
  63. Reeves WC, Cunningham D, Schwiter EJ, et al: Myocardial hydroxyproline reduced by early administration of methylprednisolone or ibuprofen to rabbits with radiation-induced heart disease. Circulation 1982:65(5):924-927.
  64. Pandian NG, Skorton DJ, Kieso RA, et al: Diagnosis of constrictive pericarditis by two-dimensional echocardiography: studies in a new experimental model and in patients. J Am Coll Cardiol 1984:4(6):1164-1173.
  65. Pagé PL, Plumb VJ, Okumura K, et al: A new animal model of atrial flutter. J Am Coll Cardiol 1986:8(4):872-879.
  66. Leak LV, Ferrans VJ, Cohen SR, et al: Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies. Am J Anat 1987:180(4):373-390.
  67. Afanasyeva M, Georgakopoulos D, Fairweather D, et al: Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice. Circulation 2004:110(18):2910-2917.
  68. d’Avila A, Neuzil P, Thiagalingam A, et al: Experimental efficacy of pericardial instillation of anti-inflammatory agents during percutaneous epicardial catheter ablation to prevent postprocedure pericarditis. J Cardiovasc Electrophysiol 2007:18(11):1178-1183.
  69. Jiamsripong P, Alharthi MS, Calleja AM, et al: Quantification of left ventricular twisting mechanics by velocity vector imaging in an animal model of pericardial adhesions. Ultrasound Med Biol 2009:35(12):1963-1972.
  70. Bokeriya LA, Bokeriya OL, Sivtsev VS, et al: Experimental Evaluation of Biodegradable Film Compositions Based on Gelatin with Colchicine. Bull Exp Biol Med 2016:161(3):414-418.
  71. Tse G, Ali A, Alpendurada F, et al: Tuberculous Constrictive Pericarditis. Res Cardiovasc Med 2015:4(4):e29614.
  72. Kim MS, Chang SA, Kim EK, et al: The Clinical Course of Tuberculous Pericarditis in Immunocompetent Hosts Based on Serial Echocardiography. Korean Circ J 2020:50(7):599-609.
  73. Isiguzo G, Du Bruyn E, Howlett P, et al: Diagnosis and Management of Tuberculous Pericarditis: What Is New?. Curr Cardiol Rep 2020:22(1):2.